KTC
ABMD

Kistler-Tiffany Companies’s Abiomed Inc ABMD Stock Holding History

Kistler-Tiffany Companies’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-465
Closed -$114K – 848
2022
Q3 		$114K Hold
465
– – 0.03% 264
2022
Q2 		$115K Hold
465
– – 0.03% 269
2022
Q1 		$154K Hold
465
– – 0.03% 248
2021
Q4 		$167K Hold
465
– – 0.03% 217
2021
Q3 		$151K Sell
465
-11
-2% -$3.73K 0.03% 217
2021
Q2 		$149K Sell
476
-75
-14% -$23K 0.03% 220
2021
Q1 		$176K Sell
551
-120
-18% -$38.4K 0.05% 184
2020
Q4 		$218K Hold
671
– – 0.06% 157
2020
Q3 		$186K Sell
671
-230
-26% -$66.3K 0.06% 151
2020
Q2 		$218K Buy
901
+381
+73% +$76.5K 0.08% 130
2020
Q1 		$89K Hold
520
– – 0.03% 201
2019
Q4 		$89K Buy
520
+330
+174% +$61.2K 0.03% 205
2019
Q3 		$34K Buy
+190
New +$41.1K 0.01% 301

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Kistler-Tiffany Companies's ABMD Position: Q4 2022 in Review

Kistler-Tiffany Companies sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 465 shares — an estimated $114K sold.

Kistler-Tiffany Companies first reported a position in ABMD in Q3 2019 and held it in 13 quarters. The position peaked at $218K in Q4 2020. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Kistler-Tiffany Companies reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Kistler-Tiffany Companies sold 465 Abiomed Inc shares in Q4 2022, an estimated $114K.
  • Kistler-Tiffany Companies first reported a position in Abiomed Inc in Q3 2019 and held it in 13 quarters.
  • Kistler-Tiffany Companies's Abiomed Inc position peaked at $218K in Q4 2020.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Kistler-Tiffany Companies's 13F filing for Q4 2022, filed 30 Jan 2023.